Invention Grant
- Patent Title: 4-Biarylyl-1-phenylazetidin-2-ones
- Patent Title (中): 4-二亚苄基-1-苯基氮杂环丁-2-酮
-
Application No.: US10986570Application Date: 2004-11-10
-
Publication No.: US07320972B2Publication Date: 2008-01-22
- Inventor: Eduardo Martinez , John J. Talley , Stephen Antonelli , Timothy C. Barden , Regina Lundrigan-Soucy , Wayne C. Schairer , Jing-Jing Yang , Daniel P. Zimmer , Brian Cali , Mark G. Currie , Peter S. Yorgey
- Applicant: Eduardo Martinez , John J. Talley , Stephen Antonelli , Timothy C. Barden , Regina Lundrigan-Soucy , Wayne C. Schairer , Jing-Jing Yang , Daniel P. Zimmer , Brian Cali , Mark G. Currie , Peter S. Yorgey
- Applicant Address: US MA Cambridge
- Assignee: Microbia, Inc.
- Current Assignee: Microbia, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Heslin Rothenberg Farley & Mesiti, P.C.
- Agent Philip E. Hansen
- Main IPC: C07D205/08
- IPC: C07D205/08 ; A61K31/397 ; A61K31/7052 ; A61P3/06 ; A61P9/10
Abstract:
4-Biarylyl-1-phenylazetidin-2-ones useful for the treatment of hypercholesterolemia are disclosed. The compounds are of the general formula in which represents an aryl or heteroaryl residue; Ar represents an aryl residue; U is a two to six atom chain; and the R's represent substituents.
Public/Granted literature
- US20050209165A1 4-Biarylyl-1-phenylazetidin-2-ones Public/Granted day:2005-09-22
Information query
